• PrEPare for Resistance… But Don’t Panic

    A report back on Donn Colby's session Starting PrEP During Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance?

    Donn Colby talked about the people who were inadvertently prescribed PrEP during acute HIV infection. The cohort of patients he examined were mainly MSM and male, with a median age of 32 years. Fortunately, only a small proportion of those who were prescribed PrEP through the Thai Red Cross Anonymous Clinic were later found to have acute HIV infection (1 in 350). The majority were diagnosed using qualitative HIV RNA, while the remainder were diagnosed by reactive HIV serology at the 1-month visit.

  • PrEP – It’s time to let go

    A report back on Heather-Marie Schmidt's session Demedicalization of PrEP

    Heather-Marie discussed the importance of PrEP demedicalization and explored various possible strategies that can be implemented in order to improve PrEP uptake and adherence as well as to improve efficiency in health care delivery. She discussed a number of models, including nurse-led, pharmacist-led and key population led PrEP services, which have already demonstrated success in various clinics around the world.